| 摘要 |
Provided is the use of an antibody that inhibits activation of the complement cascade in the manufacture of a medicament for preventing or treating in a subject a pulmonary condition in which complement is activated, wherein said antibody has an active Fab fragment and a mutated Fc portion, and wherein the mutated Fc portion does not activate complement, wherein the medicament is suitable for co-administration with an additional active agent, and wherein said antibody is specific to C5, C5 convertase, C5a or C5b-9. (61) Addition to 538384
|
